Project System (PS) Dashboard

ECC T-Codes: CJ20N / CJI3 / CN41

Pharmaceutical technology transfers, new molecule pilot batches, process validations, and CapEx WBS tracking.

Total Tech Transfer Portfolio:₱237.0M PHP

Portfolio Progress

78%+4%

Validation stagesGates Ok

Budget Consumed

₱170.0M71.7%

Tech transfer CapEx₱237M Cap

Active Transfers

3 Projects0

Novartis, Sanofi, GSKActive

Validation Protocols

100% Passed+1

IQ / OQ / PQFDA/GMP

Equipment IQ/OQ

12 / 12 Ok0

Cleanroom qualificationComplete

Pilot Commercial Runs

4 Batches+1

Registration batchesConforming

CapEx Remaining

₱67.0MBuffer

Facility expansionAvailable

Target Go-Live Index

96.5%+2.0%

Schedule compliance>95%

Technology Transfer & Capital Project Systems (SAP PS-WBS)

(3 Active Engagements)

Project Code / WBS	Project Title	Client Partner	Current Gate	Budget Consumed	Progress	Milestone Status	Target Go-Live
PS-TT-2026-01 WBS-INT-BIO-01.4	Technology Transfer: Biosimilar Monoclonal Antibody Fill-Finish	Novartis Biologics Global	Process Validation	₱68.5M / ₱85.0M	82%	On Track	2026-12-15
PS-TT-2026-02 WBS-INT-HP-02.1	High-Potency Active Pharmaceutical Ingredient (HPAPI) Containment Line	Sanofi Oncology division	Pilot Batching	₱62.0M / ₱110.0M	58%	Milestone Reached	2027-03-30
PS-TT-2026-03 WBS-INT-PED-03.2	Pediatric Oral Suspension Reformulation with Micro-Encapsulation	GlaxoSmithKline Healthcare	Commercial Readiness	₱39.5M / ₱42.0M	95%	On Track	2026-11-15